CWH Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

CWH Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$3.54M	Buy	+14,973	New	+$3.44M	1.49%	25

Other funds holding VRTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CWH Capital Management's VRTX Position: Q4 2020 in Review

CWH Capital Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q4 2020: 14,973 shares worth $3.54M. The stake represents 1.49% of the portfolio and ranks #25 among its holdings.

971 funds tracked by Wall St. Rank hold VRTX as of Q4 2020.

CWH Capital Management held 14,973 shares of Vertex Pharmaceuticals worth $3.54M as of Q4 2020.
Vertex Pharmaceuticals was a new CWH Capital Management position in Q4 2020.
Vertex Pharmaceuticals made up 1.49% of CWH Capital Management's portfolio in Q4 2020, its #25 holding.
971 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2020.

Based on CWH Capital Management's 13F filing for Q4 2020, filed 2 Feb 2021.